Prognostic Factors in Non-Small Cell Lung Cancer Less Than 3 Centimeters: Actuarial Analysis, Accumulative Incidence and Risk Groups;Factores pronóstico en el carcinoma bronquial no microcítico menor de 3 centímetros (análisis actuarial, incidencia acumulativa y grupos de riesgo)

Archivos de Bronconeumologia

Volumn 51, Issue 9, 2015, Pages 431-439

  Peñalver Cuesta, Juan C ^a   Jordá Aragón, Carlos ^b   Mancheño Franch, Nuria ^b   Cerón Navarro, José A ^b   de Aguiar Quevedo, Karol ^a   Arrarás Martínez, Miguel ^a   Vera Sempere, Francisco J ^b   Padilla Alarcón, Jose D ^a  

^a INSTITUTO VALENCIANO DE ONCOLOGÍA   (Spain)

^b HOSPITAL UNIVERSITARIO LA FE   (Spain)

Author keywords

Cumulative incidence; Non small cell lung cancer; Risk groups; Surgery; Survival

Indexed keywords

ADULT; AGE; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PROGNOSIS; CANCER RISK; CANCER STAGING; CANCER SURVIVAL; FORCED EXPIRATORY VOLUME; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; LOBAR BRONCHUS; LUNG RESECTION; MAJOR CLINICAL STUDY; NON SMALL CELL LUNG CANCER; PLEURA; SMOKING; STATISTICAL ANALYSIS; TUMOR INVASION; CONTROLLED STUDY; FEMALE; INCIDENCE; LUNG LOBECTOMY; MALE; MIDDLE AGED; PREDICTION; RISK ASSESSMENT; RISK FACTOR; SMOKING HABIT; SYMPTOM; THORACOTOMY; TUMOR VOLUME; AGED; CARCINOMA, NON-SMALL-CELL LUNG; LUNG NEOPLASMS; MORTALITY; PATHOLOGY; PROGNOSIS; PROSPECTIVE STUDY; SURVIVAL RATE;

ACTUARIAL ANALYSIS; AGED; CARCINOMA, NON-SMALL-CELL LUNG; FEMALE; HUMANS; INCIDENCE; LUNG NEOPLASMS; MALE; MIDDLE AGED; PROGNOSIS; PROSPECTIVE STUDIES; RISK ASSESSMENT; SURVIVAL RATE; TUMOR BURDEN;

EID: 84940446723     PISSN: 03002896     EISSN: 15792129     Source Type: Journal    
DOI: 10.1016/j.arbr.2015.05.015     Document Type: Article

References (40)

1. Goldstraw P. The 7th edition of TNM in lung cancer: what now?. J Thorac Oncol. 2009, 4:671-673.
2. Detterbeck F.C., Boffa D.J., Tanoue L.T. The new lung cancer staging system. Chest. 2009, 136:260-271.
3. Giroux D.J., Rami-Porta R., Chansky K., Crowley J.J., Groome P.A., Postmus P.E., et al. The IASLC Lung Cancer Staging Project: data elements for the prospective project. J Thorac Oncol. 2009, 4:679-683.
4. Travis W.D., Brambilla E., Rami-Porta R., Vallieres E., Tsuboi M., Rusch V., et al. Visceral pleural invasion: pathologic criteria and use of elastic stains: proposal for the 7th edition of the TNM classification for lung cancer. J Thorac Oncol. 2008, 3:1384-1390.
5. Maeda R., Yoshida J., Ishii G., Hishida T., Aokage K., Nishimura M., et al. Long-term survival and risk factors for recurrence in stage I non-small cell lung cancer patients with tumors up to 3cm in maximum dimension. Chest. 2010, 138:357-362.
6. Travis W.D., Brambilla E., Noguchi M., Nicholson A.G., Geisinger K.R., Yatabe T., et al. International Association for the Study of Lung Cancer/American Thoracic Society/European Respiratory Society International Multidisciplinary Classification of Lung Adenocarcinoma. J Thorac Oncol. 2011, 6:244-285.
7. Kratz J.R., He J., Van Den Eeden S.K., Zhu Z.H., Gao W., Pham P.T., et al. A practical molecular assay to predict survival in resected non-squamous, non-small-cell lung cancer: development and international validation studies. Lancet. 2012, 379:823-832.
8. Padilla J., Calvo V., Peñalver J.C., Zarza A.G., Pastor J., Blasco E., et al. Survival and risk model for stage IB non-small cell lung cancer. Lung Cancer. 2002, 36:43-48.
9. Maeda R., Yoshida J., Ishii G., Hishida T., Nishimura M., Nagai K. Poor prognostic factors in patients with stage IB non-small cell lung cancer according to the seventh edition TNM classification. Chest. 2011, 139:855-861.
10. Charlson M.E., Pompei P., Ales K.L., MacKenzie C.R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987, 40:373-383.
11. Hammar S.P. Common tumors. Pulmonary Pathology 1988, 727-845. Springer-Verlag, New York. 1.st ed. D.H. Dail, S.P. Hammar (Eds.).
12. Pintilie M. Análisis de riesgos competitivos. Rev Esp de Cardiol. 2011, 64:599-605.
13. Fine J.P., Gray R.J. A proportional hazards model for subdistribution of a competing risk. J Am Stat Assoc. 1999, 94:496-509.
14. López-Encuentra A., Duque-Medina J.L., Rami-Porta R., Gómez de la Cámara A., Ferrando P. Staging in lung cancer: is 3cm a prognostic threshold in pathologic stage I non-small cell lung cancer? A multicenter study of 1.020 patients. Chest. 2002, 121:1515-1520.
15. Padilla J., Calvo V., Peñalver J.C., Jordá C., Escrivá J., García Zarza A., et al. Carcinoma broncogénico no anaplásico de células pequeñas. Estadio I y diámetro máximo de 3cm. Factores pronósticos. Arch Bronconeumol. 2004, 43:110-113.
16. Rami-Porta R., Ball D., Crowley J., Giroux D.J., Jett J., Travis W.D., et al. The IASLC Lung Cancer Staging Project: proposals for the revision of the T descriptors in the forthcoming (seventh) edition of the TNM classification for lung cancer. J Thorac Oncol. 2007, 2:593-602.
17. Strand T.E., Rostad H., Wentzel-Larsen T., von Plessen C. A population-based evaluation of the seventh edition of the TNM system for lung cancer. Eur Resp J. 2010, 36:401-407.
18. Ye C., Masterman J.R., Huberman M.S., Gandadharan S.P., McDonald D.C., Kent M.S., et al. Subdivision of the T1 size descriptor for stage I non-small cell lung cancer has prognostic value. A single institution experience. Chest. 2009, 136:710-715.
19. Suzuki M., Yoshida S., Tamura H., Wada H., Moriya Y., Hoshino H., et al. Applicability of the revised International Association for the Study of Lung Cancer staging system to operable non-small-cell lung cancers. Eur J Cardiothorac Surg. 2009, 36:1031-1036.
20. Li Z., Yu L., Lu J., Luo Q., Wu C., Liao M., et al. Analysis of the T descriptors and other prognosis factors in pathologic stage I non-small cell lung cancer in China. J Thorac Oncol. 2009, 4:702-709.
21. Yoshino I., Kawano D., Oba T., Yamazaki K., Kometani T., Maehara Y. Smoking status as a prognostic factor in patients with stage I pulmonary adenocarcinoma. Ann Thorac Surg. 2006, 81:1189-1193.
22. Nesbitt J.C., Putnam J.B., Walsh G.L., Roth J.A., Mountain C.F. Survival in early-stage non-small cell lung cancer. Ann Thorac Surg. 1995, 60:466-472.
23. Flieder D.B., Port J.L., Korst R.J., Christos P.J., Levin M.A., Becker D.E., et al. Tumor size is a determinant of stage distribution in T1 non-small cell lung cancer. Chest. 2005, 128:2304-2308.
24. Asamura H., Goya T., Koshiishi Y., Sohara Y., Tsuchiya R., Miyaoka E. How should the TNM staging system for lung cancer be revised? A simulation based on the Japanese Lung Cancer Registry populations. J Thorac Cardiovasc Surg. 2006, 132:316-319.
25. Yanagi S., Sugiura H., Morikawa T., Kaji M., Okushiba M., Kondo S., et al. Tumor size does not have prognostic significance in stage IA NSCLC. Anticancer Res. 2000, 20:115-118.
26. Patz E., Rossi S., Harpole D., Herndon J., Goodman P. Correlation of tumor size and survival in patients with stage IA non-small cell lung cancer. Chest. 2000, 117:1568-1571.
27. Ou S.H., Zell J.A., Ziogas A., Anton-Culver H. Prognostic significance of the non-size-based AJCC T2 descriptors: visceral pleura invasion, hilar atelectasis, or obstructive pneumonitis in stage IB non-small cell lung cancer is dependent on tumor size. Chest. 2008, 133:662-669.
28. Watanabe Y., Shimizu J., Oda M., Iwa T., Takashima T., Kamimura R., et al. Early hiliar lung cancer: its clinical aspect. J Surg Oncol. 1991, 48:75-80.
29. Osaki T., Nagashima A., Yoshimatsu T., Yamada S., Yasumoto K. Visceral pleural involvement in nonsmall cell lung cancer: prognostic significance. Ann Thorac Surg. 2004, 77:1769-1773.
30. Shimizu K., Yoshida J., Nagai K., Nishimura M., Ishii G., Morishita Y., et al. Visceral pleural invasion is an invasive and aggressive indicator of non-small cell lung cancer. J Thorac Cardiovasc Surg. 2005, 130:160-165.
31. Shields T. The location of station 11 pulmonary lymph nodes. J Thorac Cardiovasc Surg. 1995, 109:402-403.
32. Brechot J.M., Chevret S., Charpentier M.C., Appere de Vecchi C., Capron F., Prudent J., et al. Blood vessel and lymphatic vessel invasion in resected nonsmall cell lung carcinoma. Correlation with TNM stage and disease free and overall survival. Cancer. 1996, 78:2111-2118.
33. Pechet T.T., Carr S.R., Collins J.E., Cohn H.E., Farber J.L. Arterial invasion predicts early mortality in stage I non-small cell lung cancer. Ann Thorac Surg. 2004, 78:1748-1754.
34. Kudo Y., Saji H., Shimada Y., Matsubayashi J., Nagao T., Kakihana M., et al. Proposal on incorporating blood vessel invasion into the T classification parts as a practical staging system for stage I non-small cell lung cancer. Lung Cancer. 2013, 81:187-193.
35. Turhan K., Samancilar O., Cagirici U., Goksel T., Nart D., Cakan A., et al. The effect of blood vessel invasion on prognosis of operated stage I non-small cell lung cancer patients. Thorac Cardiovasc Surg. 2010, 58:28-31.
36. Naito Y., Goto K., Nagai K., Ishii G., Nishimura M., Yoshida J., et al. Vascular invasion is a strong prognostic factor after complete resection of node-negative non-small cell lung cancer. Chest. 2010, 138:1411-1417.
37. Ruffini E., Asioli S., Filosso P.L., Buffoni L., Bruna M.C., Mossetti C., et al. Significance of the presence of microscopic vascular invasion after complete resection of Stage I-II pT1-T2N0 non-small cell lung cancer and its relation with T-Size categories: did the 2009 7th edition of the TNM staging system miss something?. J Thorac Oncol. 2011, 6:319-326.
38. Kawachi R., Tsukada H., Nakazato Y., Takei H., Furuyashiki G., Koshi-ishi Y., et al. Early recurrence after surgical resection in patients with pathological stage I non-small cell lung cancer. Thorac Cardiovasc Surg. 2009, 57:472-475.
39. Maeda R., Yoshida J., Ishii G., Aokage K., Hishida T., Nishimura M., et al. Long-term outcome and late recurrence in patients with completely resected stage IA non-small cell lung cancer. J Thorac Oncol. 2010, 5:1246-1250.
40. DAmico T.A., Massey M., Herndon J.E., Moore M.B., Harpole D.H. A biologic risk model for stage I lung cancer: immunohistochemical analysis of 480 patients with the use of ten molecular markers. J Thorac Cardiovasc Surg. 1999, 117:736-743.